Holdings

Squadron Capital Management LLC

As of Sep 30, 2026, Squadron Capital Management LLC reported 31 positions worth US$314M. Largest: Kodiak Sciences Inc, C4 Therapeutics, Inc. and Cogent Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Kodiak Sciences Inc420KUS$39.8M−80,000Sep 30, 2026
C4 Therapeutics, Inc.9.32MUS$31M+2.12MSep 30, 2026
Cogent Biosciences, Inc.915KUS$29.3M+50,000Sep 30, 2026
Silence Therapeutics PLC2.08MUS$22.8MnewSep 30, 2026
Zentalis Pharmaceuticals, Inc.6.83MUS$18.9M+3.13MSep 30, 2026
Edgewise Therapeutics, Inc.425KUS$17.3M+135KSep 30, 2026
Relay Therapeutics, Inc.785KUS$14.2M−185KSep 30, 2026
ORIC Pharmaceuticals, Inc.1MUS$13.5MnewSep 30, 2026
Relmada Therapeutics, Inc.3.5MUS$13.2M−3.85MSep 30, 2026
Definium Therapeutics, Inc.340KUS$12.9M+255KSep 30, 2026